Introduction to Cardiovascular Issues in HIV

Can J Cardiol. 2019 Mar;35(3):233-234. doi: 10.1016/j.cjca.2018.12.009. Epub 2018 Dec 12.

Authors

David D Waters¹, Priscilla Y Hsue²

Affiliations

¹ Division of Cardiology, Zuckerberg San Francisco General Hospital, and the Department of Medicine, University of California, San Francisco, California, USA. Electronic address: David.Waters@ucsf.edu.
² Division of Cardiology, Zuckerberg San Francisco General Hospital, and the Department of Medicine, University of California, San Francisco, California, USA.

PMID: 30825945
DOI: 10.1016/j.cjca.2018.12.009

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Anti-HIV Agents / pharmacology*
Cardiovascular Diseases* / classification
Cardiovascular Diseases* / etiology
Cardiovascular Diseases* / immunology
Cardiovascular Diseases* / prevention & control
Cardiovascular System / immunology
Cardiovascular System / physiopathology
HIV Infections* / complications
HIV Infections* / physiopathology
HIV Infections* / therapy
Humans
Inflammation* / immunology
Inflammation* / physiopathology
Risk Factors

Substances

Anti-HIV Agents